BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 32155594)

  • 1. Shortening delivery times for intensity-modulated proton therapy by reducing the number of proton spots: an experimental verification.
    van de Water S; Belosi MF; Albertini F; Winterhalter C; Weber DC; Lomax AJ
    Phys Med Biol; 2020 May; 65(9):095008. PubMed ID: 32155594
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrated beam orientation and scanning-spot optimization in intensity-modulated proton therapy for brain and unilateral head and neck tumors.
    Gu W; O'Connor D; Nguyen D; Yu VY; Ruan D; Dong L; Sheng K
    Med Phys; 2018 Apr; 45(4):1338-1350. PubMed ID: 29394454
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spot-Scanning Proton Arc (SPArc) Therapy: The First Robust and Delivery-Efficient Spot-Scanning Proton Arc Therapy.
    Ding X; Li X; Zhang JM; Kabolizadeh P; Stevens C; Yan D
    Int J Radiat Oncol Biol Phys; 2016 Dec; 96(5):1107-1116. PubMed ID: 27869083
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of linear and nonlinear programming approaches for "worst case dose" and "minmax" robust optimization of intensity-modulated proton therapy dose distributions.
    Zaghian M; Cao W; Liu W; Kardar L; Randeniya S; Mohan R; Lim G
    J Appl Clin Med Phys; 2017 Mar; 18(2):15-25. PubMed ID: 28300378
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Shortening delivery times of intensity modulated proton therapy by reducing proton energy layers during treatment plan optimization.
    van de Water S; Kooy HM; Heijmen BJ; Hoogeman MS
    Int J Radiat Oncol Biol Phys; 2015 Jun; 92(2):460-8. PubMed ID: 25823447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improve the dosimetric outcome in bilateral head and neck cancer (HNC) treatment using spot-scanning proton arc (SPArc) therapy: a feasibility study.
    Liu G; Li X; Qin A; Zheng W; Yan D; Zhang S; Stevens C; Kabolizadeh P; Ding X
    Radiat Oncol; 2020 Jan; 15(1):21. PubMed ID: 32000817
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of Spot Size and Spacing on the Quality of Robustly Optimized Intensity Modulated Proton Therapy Plans for Lung Cancer.
    Liu C; Schild SE; Chang JY; Liao Z; Korte S; Shen J; Ding X; Hu Y; Kang Y; Keole SR; Sio TT; Wong WW; Sahoo N; Bues M; Liu W
    Int J Radiat Oncol Biol Phys; 2018 Jun; 101(2):479-489. PubMed ID: 29550033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Towards FLASH proton therapy: the impact of treatment planning and machine characteristics on achievable dose rates.
    van de Water S; Safai S; Schippers JM; Weber DC; Lomax AJ
    Acta Oncol; 2019 Oct; 58(10):1463-1469. PubMed ID: 31241377
    [No Abstract]   [Full Text] [Related]  

  • 9. Spot scanning proton arc therapy reduces toxicity in oropharyngeal cancer patients.
    de Jong BA; Battinelli C; Free J; Wagenaar D; Engwall E; Janssens G; Langendijk JA; Korevaar EW; Both S
    Med Phys; 2023 Mar; 50(3):1305-1317. PubMed ID: 36373893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spot delivery error predictions for intensity modulated proton therapy using robustness analysis with machine learning.
    Newpower MA; Chiang BH; Ahmad S; Chen Y
    J Appl Clin Med Phys; 2023 May; 24(5):e13911. PubMed ID: 36748663
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Robust optimization for intensity-modulated proton therapy with soft spot sensitivity regularization.
    Gu W; Ruan D; O'Connor D; Zou W; Dong L; Tsai MY; Jia X; Sheng K
    Med Phys; 2019 Mar; 46(3):1408-1425. PubMed ID: 30570164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Statistical evaluation of worst-case robust optimization intensity-modulated proton therapy plans using an exhaustive sampling approach.
    Yang Z; Li H; Li Y; Li Y; Chang Y; Li Q; Yang K; Wu G; Sahoo N; Poenisch F; Gillin M; Zhu XR; Zhang X
    Radiat Oncol; 2019 Jul; 14(1):129. PubMed ID: 31324257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prioritized efficiency optimization for intensity modulated proton therapy.
    Müller BS; Wilkens JJ
    Phys Med Biol; 2016 Dec; 61(23):8249-8265. PubMed ID: 27811403
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Robust optimization to reduce the impact of biological effect variation from physical uncertainties in intensity-modulated proton therapy.
    Bai X; Lim G; Grosshans D; Mohan R; Cao W
    Phys Med Biol; 2019 Jan; 64(2):025004. PubMed ID: 30523932
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new treatment planning approach accounting for prompt gamma range verification and interfractional anatomical changes.
    Tian L; Landry G; Dedes G; Pinto M; Kamp F; Belka C; Parodi K
    Phys Med Biol; 2020 Apr; 65(9):095005. PubMed ID: 32135530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment log files as a tool to identify treatment plan sensitivity to inaccuracies in scanned proton beam delivery.
    Belosi MF; van der Meer R; Garcia de Acilu Laa P; Bolsi A; Weber DC; Lomax AJ
    Radiother Oncol; 2017 Dec; 125(3):514-519. PubMed ID: 29054379
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Implication of spot position error on plan quality and patient safety in pencil-beam-scanning proton therapy.
    Yu J; Beltran CJ; Herman MG
    Med Phys; 2014 Aug; 41(8):081706. PubMed ID: 25086516
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A GPU-accelerated and Monte Carlo-based intensity modulated proton therapy optimization system.
    Ma J; Beltran C; Seum Wan Chan Tseung H; Herman MG
    Med Phys; 2014 Dec; 41(12):121707. PubMed ID: 25471954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dosimetric impact of random spot positioning errors in intensity modulated proton therapy plans of small and large volume tumors.
    Arjunan M; Krishnan G; Sharma DS; M P N; Patro KC; Thiyagarajan R; Srinivas C; Jalali R
    Br J Radiol; 2021 Mar; 94(1119):20201031. PubMed ID: 33529057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intensity-modulated proton therapy (IMPT) interplay effect evaluation of asymmetric breathing with simultaneous uncertainty considerations in patients with non-small cell lung cancer.
    Shan J; Yang Y; Schild SE; Daniels TB; Wong WW; Fatyga M; Bues M; Sio TT; Liu W
    Med Phys; 2020 Nov; 47(11):5428-5440. PubMed ID: 32964474
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.